In fiscal year 2022, we pledged almost $17.2 million in new grants to 58 exceptional scientists, and provided an additional $1.6 million in stipend increases, extension funding for pandemic-related research delays, and other support.

As we celebrated our 75th anniversary in 2022, we reflected on the transformative impact Damon Runyon's focused and strategic funding has had on cancer treatments. Now, as we move forward, we're knocking on the door of new breakthroughs that might have sounded impossible just a decade ago. 

2021 ANNUAL REPORT

A Year in Review

View Full Screen Download PDF

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat or click here to download the PDF file.

2022
"Funding Brave & Bold: The Next 75 Years"
2021
A Year in Review
2020
"Resilience"
2019
"Funding Brave and Bold"
2018
“The Science of Leadership”
2017
“Driven”
2016
70th Anniversary Annual Report
2015 Annual Report - Redefining Cancer
2015
"Redefining Cancer"
33% More
2014
“33% More”
2013
"Writing Success Stories"
2012
“How Do We Spot an Innovator?”
2011
“A Tipping Point in Cancer Research”
2010
“Microscopes for Briefcases?”
2009
“Building a Bridge”